Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27Kip1

Oncogene volume 20, pages 4466–4475 (2001)Cite this article

Abstract

An inverse correlation between p27Kip1 expression and proliferation has been recently established in tissues derived from human lymphomas. The nucleophosmin-anaplastic lymphoma kinase (NPM–ALK)/phospholipase C-γ (PLCγ) complex also appears to play an important role in cell proliferation and malignant transformation of anaplastic large cell lymphoma (ALCL). In this study, we report that SUDHL-1 and KARPAS 299 ALCL-derived cell lines present different sensitivity to the antiproliferative effect of recombinant adenovirus-mediated p27Kip1 expression or to serum-starvation in culture media. The results indicate that exogenous p27Kip1 may interact with the NPM–ALK/PLCγ pathway in SUDHL-1 but not in KARPAS 299 cells. This interaction correlates with changes in cell cycle and cell morphology observed mainly in SUDHL-1 cells. The percentage of SUDHL-1 cells in S phase declines, whereas it is almost unchanged in KARPAS 299 cells as compared to the controls after 96 h of infection with the recombinant adenovirus. Furthermore KARPAS 299 cells are resistant to serum-starvation due to deficient p27Kip1-upregulation and G1 arrest, whereas SUDHL-1 cells respond with increased G1 phase and p27Kip1-upregulation after 48 h of serum-starvation. Both cell lines express appropriate variation of levels of cyclins E and A, and Rb-phosphorylation as expected by growing them in culture media with different FBS content. Although both cell lines express cyclin D2, SUDHL-1 cells only present high level of cyclin D3. Moreover SUDHL-1 cells express high level of PTEN and the PKB/Akt pathway is constitutively activated in both cell lines. Lastly SUDHL-1 cells show higher levels of phosphotyrosine-containing proteins that is correlated with a higher NPM–ALK-associated autophosphorylation activity compared to KARPAS 299 cells. Our study clearly identifies some of the biochemical differences that may explain the difference in sensitivity to antiproliferative stimuli shown by two cell lines derived from the same type of lymphoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Bai R-Y, Dieter P, Peschel C, Morris SW, Duyster J . 1998 Mol. Cell. Biol. 18: 6951–6961

  • Bai R-Y, Ouyang T, Miething C, Morris SW, Peschel C, Duyster J . 2000 Blood 96: 4319–4327

  • Bischoff D, Pulford K, Mason DY, Morris SW . 1997 Mol. Cell. Biol. 17: 2312–2325

  • Craig C, Wresto R, Kim R, Ohri E, Li Z, Katayose D, Lee SJ, Trepel J, Cowan K, Seth P . 1997 Oncogene 14: 2283–2289

  • Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP . 2000 Mol. Biol. Cell 11: 1061–1076

  • Di Cristofano A, Pandolfi PP . 2000 Cell 100: 387–390

  • Falini B, Pulford K, Pucciarini A, Carbone A, De Wolf-Peeters C, Cordell J, Fizzotti M, Santucci A, Pellicci PG, Pileri S, Campo E, Ott G, Delsol G, Mason DY . 1999 Blood 94: 3509–3515

  • Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FGJ, Karpas A . 1988 Blood 72: 234–240

  • Gesbert F, Sellers WR, Signoretti S, Loda M, Griffin JD . 2000 J. Biol. Chem. 275: 39223–39230

  • Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Ralfkiaer E, Warnke RA . 1994 Blood 84: 1361–1392

  • Hubinger G, Scheffrahn I, Muller E, Bai R, Duyster J, Morris SW, Schrezenmeier H, Bergmann L . 1999 Exp. Hem. 27: 1796–1805

  • Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H . 2000 Cancer Res. 60: 6201–6207

  • Jiang Y, Zhao RCH, Verfaille CM . 2000 Proc. Natl. Acad. Sci. USA 97: 10538–10543

  • Jonuleit T, van der Kuip H, Miething C, Michels H, Hallek M, Duyster J, Aulitzky WE . 2000 Blood 96: 1933–1939

  • Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW . 1997 Blood 90: 2901–2910

  • Lloyd RV, Lori A, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, Scheithauer BW . 1999 Am. J. Pathol. 154: 313–323

  • Mason DY, Pulford KAF, Bischof D, Kuefer MU, Butler LH, Lamant L, Delsol G, Morris SW . 1998 Cancer Res. 58: 1057–1062

  • Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R, Cleary ML . 1989 Blood 73: 2155–2164

  • Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT . 1994 Science 263: 1281–1284

  • Okuda M, Horn HF, Tarapore PJD, Bove KE, Fukasawa K . 2000 Cell 103: 127–140

  • Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR . 1999 Proc. Natl. Acad. Sci. USA 96: 2110–2115

  • Sakai A, Thieblemont C, Wellmann A, Jaffe ES, Raffeld M . 1998 Blood 92: 3410–3415

  • Sanchez-Beato M, Camacho FI, Martinez-Montero JC, Sol MM, Sanchez-Verde L, Villuendas R, Troncone G, Piris MA . 1997 Am. J. Pathol. 151: 151–160

  • Sawyers CL, Denny CT . 1994 Cell 77: 171–173

  • Sgambato A, Cittadini A, Faraglia B, Weinstein IB . 2000 J. Cell Physiol. 183: 18–27

  • Sherr JS, Roberts JM . 1995 Genes Dev. 9: 1149–1163

  • Sherr JS . 2000 Cancer Res. 60: 3689–3695

  • Spector DL, Ochs RL, Busch H . 1984 Chromosoma 90: 139–148

  • Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW . 1998 Cell 95: 29–39

  • Suzuki R, Kuroda H, Komatsu H, Hosokawa Y, Kagami Y, Ogura M, Nakamura S, Kodera Y, Morishima Y, Ueda R, Seto M . 1999 Leukemia 13: 1335–1342

  • Szebeni A, Olson MO . 1999 Protein Sci. 8: 905–912

  • Turturro F, Seth P, Link CJ . 2000a Clin. Cancer Res. 6: 185–192

  • Turturro F, Heineke HL, Drevyanko TF, Link Jr CJ, Seth P . 2000b Gene Ther. 7: 930–933

  • Turturro F, Frist A, Seth P . 2000c Mol. Ther. 1: S323

  • Ullrich A, Schlessinger J . 1990 Cell 61: 203–212

  • Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL . 1998 Proc. Natl. Acad. Sci. USA 95: 15187–15591

Download references

Acknowledgements

This work was supported by grants from Des Moines Research and Education VA Central lowa Health Care System and from Research and Innovation Center, Central lowa Health System, Des Moines, lowa, (F Turturro) and the Leukaemia Research Fund of the United Kingdom (K Pulford).

Author information

Authors and Affiliations

  1. Human Gene Therapy Research Institute, John Stoddard Cancer Center, Iowa Methodist Medical Center, Iowa, USA

    Francesco Turturro, Audrey Y Frist & Marilyn D Arnold

  2. Division of Hematology-Oncology, VA Central Iowa Health Care System, Des Moines, 50309, Iowa, IA, USA

    Francesco Turturro

  3. University Research, Des Moines University, Des Moines, 50312, Iowa, IA, USA

    Prem Seth

  4. Nuffield Department, Clinical Laboratory Sciences, Room 5501, Level 5, John Radcliffe Hospital, Oxford, OX3 9DU, UK

    Karen Pulford

Authors
  1. Francesco Turturro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Audrey Y Frist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marilyn D Arnold
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prem Seth
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karen Pulford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turturro, F., Frist, A., Arnold, M. et al. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27Kip1. Oncogene 20, 4466–4475 (2001). https://doi.org/10.1038/sj.onc.1204582

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204582

Keywords

This article is cited by

Search

Advanced search

Quick links